Alice Melão, MSc,  —

Articles by Alice Melão

Santhera to Develop, Market Polyphor Experimental CF Therapy

Santhera Pharmaceuticals has bought the rights to POL6014, a medication being developed by Polyphor to treat cystic fibrosis (CF) and other pulmonary diseases. Under terms of the global licensing agreement between the two Swiss companies, Santhera will develop, handle regulatory filings and market the investigative drug and derivate…

EU Approves Vertex’s Orkambi to Treat CF Children Ages 6 to 11

Some 3,400 European children whose cystic fibrosis (CF) is caused by the CFTR F508del mutation may now receive Orkambi (lumacaftor/ivacaftor), thanks to the European Commission’s decision to extend the therapy’s marketing authorization. The Jan. 10 extension, which applies to children aged 6 to 11, follows a positive recommendation issued…

Top 10 Cystic Fibrosis Articles of 2017

A number of cystic fibrosis discoveries, therapy advances and other developments were reported by Cystic Fibrosis News Today during 2017. Now that the year is over, it’s time to review the articles that appealed most to our readers. Here are the 10 most-read articles of 2017, with a brief description of what…